https://www.selleckchem.com/pr....oducts/a-d-glucose-a
g., C-reactive protein, SDC 0.9mg/dl, vs. UDC 2.0mg/dl vs. pre-ACLF 3.2mg/dl, p0.001) while renal function was progressively deteriorating (creatinine levels, SDC 0.8mg/dl vs. UDC 0.9mg/dl vs. pre-ACLF 1.2mg/dl, p0.001) across prognostic subgroups in patients with cirrhosis. The recently proposed pathophysiological/prognostic EF-CLIF subgroups are also reproduceable in a real-life cohort of cirrhotic patients. As ACLF is a common and important complication, patients at risk of pre-ACLF at index AD should be evaluat
Like
Comment
Share
